MG
LJPC

Michael Gelband’s La Jolla Pharmaceutical Company LJPC Stock Holding History

Michael Gelband’s Portfolio LJPC Stock Details LJPC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-10,073
Closed -$43K – 2946
2021
Q2 		$43K Sell
10,073
-1,514
-13% -$6.49K ﹤0.01% 2236
2021
Q1 		$49K Buy
+11,587
New +$63.8K ﹤0.01% 2033
2020
Q3 		– Sell
-10,940
Closed -$47K – 2468
2020
Q2 		$47K Buy
+10,940
New +$66.6K ﹤0.01% 1687
2019
Q4 		– Sell
-19,619
Closed -$173K – 2082
2019
Q3 		$173K Buy
19,619
+7,302
+59% +$69K 0.01% 1160
2019
Q2 		$114K Buy
+12,317
New +$92.8K ﹤0.01% 1013

Other funds holding LJPC

TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
HP
HealthInvest Partners Stockholm, Sweden $372M AUM 59.89% 1-Year Est. Return
KT
Kevin Tang $783 AUM 75.59% 1-Year Est. Return

Michael Gelband's LJPC Position: Q3 2021 in Review

Michael Gelband sold out of La Jolla Pharmaceutical Company (LJPC) in Q3 2021, closing a stake of 10,073 shares — an estimated $43K sold.

Michael Gelband first reported a position in LJPC in Q2 2019 and held it in 5 quarters. The position peaked at $173K in Q3 2019. 54 funds tracked by Wall St. Rank hold LJPC as of Q3 2021.

  • Michael Gelband reported no remaining La Jolla Pharmaceutical Company position as of Q3 2021 after selling out during the quarter.
  • Michael Gelband sold 10,073 La Jolla Pharmaceutical Company shares in Q3 2021, an estimated $43K.
  • Michael Gelband first reported a position in La Jolla Pharmaceutical Company in Q2 2019 and held it in 5 quarters.
  • Michael Gelband's La Jolla Pharmaceutical Company position peaked at $173K in Q3 2019.
  • 54 funds tracked by Wall St. Rank held La Jolla Pharmaceutical Company as of Q3 2021.

Based on ExodusPoint Capital Management's 13F filing for Q3 2021, filed 15 Nov 2021.